{{Rsnum
|rsid=9333025
|Gene=CYP4A11
|Chromosome=1
|position=46931231
|Orientation=minus
|GMAF=0.1423
|Gene_s=CYP4A11
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 13.3 | 85.0
| HCB | 5.8 | 33.6 | 60.6
| JPT | 8.0 | 47.8 | 44.2
| YRI | 0.7 | 14.4 | 84.9
| ASW | 1.8 | 17.5 | 80.7
| CHB | 5.8 | 33.6 | 60.6
| CHD | 1.8 | 25.7 | 72.5
| GIH | 1.0 | 9.9 | 89.1
| LWK | 0.0 | 19.1 | 80.9
| MEX | 1.7 | 19.0 | 79.3
| MKK | 0.0 | 0.0 | 0.0
| TSI | 1.0 | 8.9 | 90.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=22804341
|Title=Haplotype-based case-control study of CYP4A11 gene and myocardial infarction
}}

{{PMID Auto
|PMID=18300855
|Title=A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men.
}}

{{PMID Auto
|PMID=18484194
|Title=Haplotype-based case study of human CYP4A11 gene and cerebral infarction in Japanese subject.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}